#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=Maize is grown worldwide , with the United States , China , and Brazil ranked as the leading producing countries contributing approximately 563 of the 717 million metric tonnes per year .
3-1	17-22	Maize	plant	new	coref	4-3[11_0]
3-2	23-25	is	_	_	_	_
3-3	26-31	grown	_	_	_	_
3-4	32-41	worldwide	_	_	_	_
3-5	42-43	,	_	_	_	_
3-6	44-48	with	_	_	_	_
3-7	49-52	the	place[4]	new[4]	_	_
3-8	53-59	United	place[4]	new[4]	_	_
3-9	60-66	States	place[4]	new[4]	_	_
3-10	67-68	,	place[4]	new[4]	_	_
3-11	69-74	China	place[4]|place	new[4]|new	_	_
3-12	75-76	,	_	_	_	_
3-13	77-80	and	_	_	_	_
3-14	81-87	Brazil	place	new	_	_
3-15	88-94	ranked	_	_	_	_
3-16	95-97	as	_	_	_	_
3-17	98-101	the	_	_	_	_
3-18	102-109	leading	_	_	_	_
3-19	110-119	producing	_	_	_	_
3-20	120-129	countries	_	_	_	_
3-21	130-142	contributing	_	_	_	_
3-22	143-156	approximately	quantity[7]	new[7]	_	_
3-23	157-160	563	quantity[7]	new[7]	_	_
3-24	161-163	of	quantity[7]	new[7]	_	_
3-25	164-167	the	quantity[7]|quantity[9]	new[7]|new[9]	_	_
3-26	168-171	717	quantity[7]|quantity[9]	new[7]|new[9]	_	_
3-27	172-179	million	quantity[7]|quantity[9]	new[7]|new[9]	_	_
3-28	180-186	metric	quantity[7]|abstract|quantity[9]	new[7]|new|new[9]	_	_
3-29	187-193	tonnes	quantity[7]|quantity[9]	new[7]|new[9]	_	_
3-30	194-197	per	quantity[7]|quantity[9]	new[7]|new[9]	_	_
3-31	198-202	year	quantity[7]|quantity[9]|time	new[7]|new[9]|new	_	_
3-32	203-204	.	_	_	_	_

#Text=However , maize , like other cereals , is susceptible to contamination by mycotoxins , including T-2 toxin .
4-1	205-212	However	_	_	_	_
4-2	213-214	,	_	_	_	_
4-3	215-220	maize	plant[11]	giv[11]	coref	5-17[0_11]
4-4	221-222	,	plant[11]	giv[11]	_	_
4-5	223-227	like	plant[11]	giv[11]	_	_
4-6	228-233	other	plant[11]|substance[12]	giv[11]|new[12]	_	_
4-7	234-241	cereals	plant[11]|substance[12]	giv[11]|new[12]	_	_
4-8	242-243	,	_	_	_	_
4-9	244-246	is	_	_	_	_
4-10	247-258	susceptible	_	_	_	_
4-11	259-261	to	_	_	_	_
4-12	262-275	contamination	abstract[13]	new[13]	_	_
4-13	276-278	by	abstract[13]	new[13]	_	_
4-14	279-289	mycotoxins	abstract[13]|substance	new[13]|new	coref	8-8
4-15	290-291	,	abstract[13]	new[13]	_	_
4-16	292-301	including	abstract[13]	new[13]	_	_
4-17	302-305	T-2	abstract[13]|substance[15]	new[13]|new[15]	coref	5-1[17_15]
4-18	306-311	toxin	abstract[13]|substance[15]	new[13]|new[15]	_	_
4-19	312-313	.	_	_	_	_

#Text=T-2 toxin is common in grains , including oats , soybeans , rice , barley , maize , and wheat .
5-1	314-317	T-2	abstract|substance[17]	new|giv[17]	coref|coref|coref|coref	7-23[37_17]|9-17|7-23[37_17]|9-17
5-2	318-323	toxin	substance[17]	giv[17]	_	_
5-3	324-326	is	_	_	_	_
5-4	327-333	common	_	_	_	_
5-5	334-336	in	_	_	_	_
5-6	337-343	grains	substance[18]	new[18]	_	_
5-7	344-345	,	substance[18]	new[18]	_	_
5-8	346-355	including	substance[18]	new[18]	_	_
5-9	356-360	oats	substance[18]|substance	new[18]|new	_	_
5-10	361-362	,	substance[18]	new[18]	_	_
5-11	363-371	soybeans	substance[18]|plant	new[18]|new	_	_
5-12	372-373	,	substance[18]	new[18]	_	_
5-13	374-378	rice	substance[18]|substance	new[18]|new	_	_
5-14	379-380	,	substance[18]	new[18]	_	_
5-15	381-387	barley	substance[18]|object	new[18]|new	_	_
5-16	388-389	,	substance[18]	new[18]	_	_
5-17	390-395	maize	substance[18]|plant	new[18]|giv	_	_
5-18	396-397	,	substance[18]	new[18]	_	_
5-19	398-401	and	substance[18]	new[18]	_	_
5-20	402-407	wheat	substance[18]|plant	new[18]|new	_	_
5-21	408-409	.	_	_	_	_

#Text=Fusarium langsethiae
6-1	410-418	Fusarium	animal|animal[26]	new|new[26]	coref|coref	7-8|7-8
6-2	419-430	langsethiae	animal[26]	new[26]	_	_

#Text=and F. sporotrichioides are some of the Fusarium species that infect crops in the field and storage during which time they produce T-2 toxin .
7-1	431-434	and	_	_	_	_
7-2	435-437	F.	person|plant[28]	new|new[28]	coref|coref	8-16[42_28]|8-16[42_28]
7-3	438-454	sporotrichioides	plant[28]	new[28]	_	_
7-4	455-458	are	_	_	_	_
7-5	459-463	some	_	_	_	_
7-6	464-466	of	_	_	_	_
7-7	467-470	the	plant[30]	new[30]	_	_
7-8	471-479	Fusarium	animal|plant[30]	giv|new[30]	coref	8-16
7-9	480-487	species	plant[30]	new[30]	_	_
7-10	488-492	that	_	_	_	_
7-11	493-499	infect	_	_	_	_
7-12	500-505	crops	plant	new	_	_
7-13	506-508	in	_	_	_	_
7-14	509-512	the	place[32]|place[33]	new[32]|new[33]	ana|ana	7-21[0_33]|7-21[0_33]
7-15	513-518	field	place[32]|place[33]	new[32]|new[33]	_	_
7-16	519-522	and	place[33]	new[33]	_	_
7-17	523-530	storage	place[33]|place	new[33]|new	_	_
7-18	531-537	during	_	_	_	_
7-19	538-543	which	time[35]	new[35]	_	_
7-20	544-548	time	time[35]	new[35]	_	_
7-21	549-553	they	place	giv	_	_
7-22	554-561	produce	_	_	_	_
7-23	562-565	T-2	substance[37]	giv[37]	coref	8-1[38_37]
7-24	566-571	toxin	substance[37]	giv[37]	_	_
7-25	572-573	.	_	_	_	_

#Text=This toxin belongs to the family of mycotoxins known as the trichothecenes produced mainly by Fusarium sporotrichioides , F. graminearum , F. poae , and F. culmorum and causing diarrhea , inflammation , and emesis .
8-1	574-578	This	substance[38]	giv[38]	coref	9-17[52_38]
8-2	579-584	toxin	substance[38]	giv[38]	_	_
8-3	585-592	belongs	_	_	_	_
8-4	593-595	to	_	_	_	_
8-5	596-599	the	abstract[39]	new[39]	_	_
8-6	600-606	family	abstract[39]	new[39]	_	_
8-7	607-609	of	abstract[39]	new[39]	_	_
8-8	610-620	mycotoxins	abstract[39]|person	new[39]|giv	ana	9-1
8-9	621-626	known	_	_	_	_
8-10	627-629	as	_	_	_	_
8-11	630-633	the	_	_	_	_
8-12	634-648	trichothecenes	_	_	_	_
8-13	649-657	produced	_	_	_	_
8-14	658-664	mainly	_	_	_	_
8-15	665-667	by	_	_	_	_
8-16	668-676	Fusarium	place|plant[42]	giv|giv[42]	_	_
8-17	677-693	sporotrichioides	plant[42]	giv[42]	_	_
8-18	694-695	,	_	_	_	_
8-19	696-698	F.	_	_	_	_
8-20	699-710	graminearum	_	_	_	_
8-21	711-712	,	_	_	_	_
8-22	713-715	F.	_	_	_	_
8-23	716-720	poae	_	_	_	_
8-24	721-722	,	_	_	_	_
8-25	723-726	and	_	_	_	_
8-26	727-729	F.	_	_	_	_
8-27	730-738	culmorum	_	_	_	_
8-28	739-742	and	_	_	_	_
8-29	743-750	causing	_	_	_	_
8-30	751-759	diarrhea	abstract	new	_	_
8-31	760-761	,	_	_	_	_
8-32	762-774	inflammation	abstract	new	coref	18-15[102_0]
8-33	775-776	,	_	_	_	_
8-34	777-780	and	_	_	_	_
8-35	781-787	emesis	abstract	new	_	_
8-36	788-789	.	_	_	_	_

#Text=They can be grouped into Type A , B , C , and D , with T-2 toxin belonging to Type A trichothecenes , the most toxic group of trichothecenes .
9-1	790-794	They	person	giv	coref	10-4[58_0]
9-2	795-798	can	_	_	_	_
9-3	799-801	be	_	_	_	_
9-4	802-809	grouped	_	_	_	_
9-5	810-814	into	_	_	_	_
9-6	815-819	Type	object	new	coref	9-21
9-7	820-821	A	_	_	_	_
9-8	822-823	,	_	_	_	_
9-9	824-825	B	place	new	_	_
9-10	826-827	,	_	_	_	_
9-11	828-829	C	person	new	_	_
9-12	830-831	,	_	_	_	_
9-13	832-835	and	_	_	_	_
9-14	836-837	D	person	new	_	_
9-15	838-839	,	_	_	_	_
9-16	840-844	with	_	_	_	_
9-17	845-848	T-2	abstract|substance[52]	giv|giv[52]	coref|coref|coref|coref	11-2|13-5[81_52]|11-2|13-5[81_52]
9-18	849-854	toxin	substance[52]	giv[52]	_	_
9-19	855-864	belonging	_	_	_	_
9-20	865-867	to	_	_	_	_
9-21	868-872	Type	abstract	giv	_	_
9-22	873-874	A	substance[54]	new[54]	coref	9-30[0_54]
9-23	875-889	trichothecenes	substance[54]	new[54]	_	_
9-24	890-891	,	_	_	_	_
9-25	892-895	the	abstract[55]	new[55]	coref	11-16[66_55]
9-26	896-900	most	abstract[55]	new[55]	_	_
9-27	901-906	toxic	abstract[55]	new[55]	_	_
9-28	907-912	group	abstract[55]	new[55]	_	_
9-29	913-915	of	abstract[55]	new[55]	_	_
9-30	916-930	trichothecenes	abstract[55]|substance	new[55]|giv	coref	10-1
9-31	931-932	.	_	_	_	_

#Text=Trichothecenes are among the mycotoxins associated with human and veterinary diseases .
10-1	933-947	Trichothecenes	substance	giv	coref	11-4[61_0]
10-2	948-951	are	_	_	_	_
10-3	952-957	among	_	_	_	_
10-4	958-961	the	substance[58]	giv[58]	coref	24-23[0_58]
10-5	962-972	mycotoxins	substance[58]	giv[58]	_	_
10-6	973-983	associated	_	_	_	_
10-7	984-988	with	_	_	_	_
10-8	989-994	human	abstract[59]	new[59]	_	_
10-9	995-998	and	abstract[59]	new[59]	_	_
10-10	999-1009	veterinary	abstract[59]	new[59]	_	_
10-11	1010-1018	diseases	abstract[59]	new[59]	_	_
10-12	1019-1020	.	_	_	_	_

#Text=Like T-2 , all trichothecenes have a common tetracyclic sesquiterpenoid 12,13-epoxytrichothec-9-ene ring system together with an epoxide group located at their C12 , C13 positions , which accounts for their toxicity .
11-1	1021-1025	Like	_	_	_	_
11-2	1026-1029	T-2	substance	giv	coref	13-5
11-3	1030-1031	,	_	_	_	_
11-4	1032-1035	all	substance[61]	giv[61]	ana	11-21[0_61]
11-5	1036-1050	trichothecenes	substance[61]	giv[61]	_	_
11-6	1051-1055	have	_	_	_	_
11-7	1056-1057	a	place[64]	new[64]	coref	23-23[137_64]
11-8	1058-1064	common	place[64]	new[64]	_	_
11-9	1065-1076	tetracyclic	organization|place[64]	new|new[64]	_	_
11-10	1077-1092	sesquiterpenoid	place[64]	new[64]	_	_
11-11	1093-1120	12,13-epoxytrichothec-9-ene	place[64]	new[64]	_	_
11-12	1121-1125	ring	abstract|place[64]	new|new[64]	_	_
11-13	1126-1132	system	place[64]	new[64]	_	_
11-14	1133-1141	together	place[64]	new[64]	_	_
11-15	1142-1146	with	_	_	_	_
11-16	1147-1149	an	abstract[66]	giv[66]	_	_
11-17	1150-1157	epoxide	abstract|abstract[66]	new|giv[66]	_	_
11-18	1158-1163	group	abstract[66]	giv[66]	_	_
11-19	1164-1171	located	_	_	_	_
11-20	1172-1174	at	_	_	_	_
11-21	1175-1180	their	substance|place[68]	giv|new[68]	ana|ana	11-30|11-30
11-22	1181-1184	C12	place[68]	new[68]	_	_
11-23	1185-1186	,	_	_	_	_
11-24	1187-1190	C13	place|abstract[70]	new|new[70]	_	_
11-25	1191-1200	positions	abstract[70]	new[70]	_	_
11-26	1201-1202	,	_	_	_	_
11-27	1203-1208	which	_	_	_	_
11-28	1209-1217	accounts	_	_	_	_
11-29	1218-1221	for	_	_	_	_
11-30	1222-1227	their	substance|abstract[72]	giv|new[72]	coref|coref	12-1[73_72]|12-1[73_72]
11-31	1228-1236	toxicity	abstract[72]	new[72]	_	_
11-32	1237-1238	.	_	_	_	_

#Text=T-2 toxicity is induced via oxidative stress-mediated deoxyribonucleic acid ( DNA ) damage and apoptosis .
12-1	1239-1242	T-2	abstract[73]	giv[73]	coref	21-25[124_73]
12-2	1243-1251	toxicity	abstract[73]	giv[73]	_	_
12-3	1252-1254	is	_	_	_	_
12-4	1255-1262	induced	_	_	_	_
12-5	1263-1266	via	_	_	_	_
12-6	1267-1276	oxidative	substance[75]	new[75]	appos	12-11[0_75]
12-7	1277-1292	stress-mediated	substance[75]	new[75]	_	_
12-8	1293-1309	deoxyribonucleic	abstract|substance[75]	new|new[75]	_	_
12-9	1310-1314	acid	substance[75]	new[75]	_	_
12-10	1315-1316	(	_	_	_	_
12-11	1317-1320	DNA	substance	giv	_	_
12-12	1321-1322	)	_	_	_	_
12-13	1323-1329	damage	abstract	new	_	_
12-14	1330-1333	and	_	_	_	_
12-15	1334-1343	apoptosis	event	new	_	_
12-16	1344-1345	.	_	_	_	_

#Text=The chemical structure of T-2 toxin is shown in
13-1	1346-1349	The	abstract[79]	new[79]	_	_
13-2	1350-1358	chemical	abstract[79]	new[79]	_	_
13-3	1359-1368	structure	abstract[79]	new[79]	_	_
13-4	1369-1371	of	abstract[79]	new[79]	_	_
13-5	1372-1375	T-2	abstract[79]|abstract|substance[81]	new[79]|giv|giv[81]	coref|coref|coref|coref	16-1|16-1[84_81]|16-1|16-1[84_81]
13-6	1376-1381	toxin	abstract[79]|substance[81]	new[79]|giv[81]	_	_
13-7	1382-1384	is	_	_	_	_
13-8	1385-1390	shown	_	_	_	_
13-9	1391-1393	in	_	_	_	_

#Text=Figure 1
14-1	1394-1400	Figure	object[82]	new[82]	_	_
14-2	1401-1402	1	object[82]	new[82]	_	_

#Text=.
15-1	1403-1404	.	_	_	_	_

#Text=T-2 toxin is a recognized inhibitor of protein synthesis , which occurs by the binding of peptidyl transferase , present in the 60S ribosomal subunit .
16-1	1405-1408	T-2	abstract|substance[84]	giv|giv[84]	coref|coref|coref|coref	16-4[85_84]|17-1|16-4[85_84]|17-1
16-2	1409-1414	toxin	substance[84]	giv[84]	_	_
16-3	1415-1417	is	_	_	_	_
16-4	1418-1419	a	substance[85]	giv[85]	coref	18-1[98_85]
16-5	1420-1430	recognized	substance[85]	giv[85]	_	_
16-6	1431-1440	inhibitor	substance[85]	giv[85]	_	_
16-7	1441-1443	of	substance[85]	giv[85]	_	_
16-8	1444-1451	protein	substance[85]|substance|abstract[87]	giv[85]|new|new[87]	_	_
16-9	1452-1461	synthesis	substance[85]|abstract[87]	giv[85]|new[87]	_	_
16-10	1462-1463	,	_	_	_	_
16-11	1464-1469	which	_	_	_	_
16-12	1470-1476	occurs	_	_	_	_
16-13	1477-1479	by	_	_	_	_
16-14	1480-1483	the	event[88]	new[88]	_	_
16-15	1484-1491	binding	event[88]	new[88]	_	_
16-16	1492-1494	of	event[88]	new[88]	_	_
16-17	1495-1503	peptidyl	event[88]|abstract|object[90]	new[88]|new|new[90]	_	_
16-18	1504-1515	transferase	event[88]|object[90]	new[88]|new[90]	_	_
16-19	1516-1517	,	_	_	_	_
16-20	1518-1525	present	_	_	_	_
16-21	1526-1528	in	_	_	_	_
16-22	1529-1532	the	object[93]	new[93]	_	_
16-23	1533-1536	60S	abstract|object[93]	new|new[93]	_	_
16-24	1537-1546	ribosomal	animal|object[93]	new|new[93]	_	_
16-25	1547-1554	subunit	object[93]	new[93]	_	_
16-26	1555-1556	.	_	_	_	_

#Text=T-2 poisoning in man results in alimentary toxic aleukia ( ATA ) .
17-1	1557-1560	T-2	abstract	giv	coref	20-1
17-2	1561-1570	poisoning	_	_	_	_
17-3	1571-1573	in	_	_	_	_
17-4	1574-1577	man	person	new	_	_
17-5	1578-1585	results	_	_	_	_
17-6	1586-1588	in	_	_	_	_
17-7	1589-1599	alimentary	abstract[96]	new[96]	appos	17-11[0_96]
17-8	1600-1605	toxic	abstract[96]	new[96]	_	_
17-9	1606-1613	aleukia	abstract[96]	new[96]	_	_
17-10	1614-1615	(	_	_	_	_
17-11	1616-1619	ATA	abstract	giv	_	_
17-12	1620-1621	)	_	_	_	_
17-13	1622-1623	.	_	_	_	_

#Text=The toxin also causes ulcers as well as necrosis in the digestive tract , hemorrhagic inflammation , and dystrophy in the brain , heart , kidney , and liver .
18-1	1624-1627	The	substance[98]	giv[98]	coref	21-18[122_98]
18-2	1628-1633	toxin	substance[98]	giv[98]	_	_
18-3	1634-1638	also	_	_	_	_
18-4	1639-1645	causes	_	_	_	_
18-5	1646-1652	ulcers	person	new	_	_
18-6	1653-1655	as	_	_	_	_
18-7	1656-1660	well	_	_	_	_
18-8	1661-1663	as	_	_	_	_
18-9	1664-1672	necrosis	abstract[100]	new[100]	_	_
18-10	1673-1675	in	abstract[100]	new[100]	_	_
18-11	1676-1679	the	abstract[100]|object[101]	new[100]|new[101]	coref	23-11[134_101]
18-12	1680-1689	digestive	abstract[100]|object[101]	new[100]|new[101]	_	_
18-13	1690-1695	tract	abstract[100]|object[101]	new[100]|new[101]	_	_
18-14	1696-1697	,	abstract[100]	new[100]	_	_
18-15	1698-1709	hemorrhagic	abstract[100]|abstract[102]	new[100]|giv[102]	_	_
18-16	1710-1722	inflammation	abstract[100]|abstract[102]	new[100]|giv[102]	_	_
18-17	1723-1724	,	abstract[100]	new[100]	_	_
18-18	1725-1728	and	abstract[100]	new[100]	_	_
18-19	1729-1738	dystrophy	abstract[100]|abstract[103]	new[100]|new[103]	_	_
18-20	1739-1741	in	abstract[100]|abstract[103]	new[100]|new[103]	_	_
18-21	1742-1745	the	abstract[100]|abstract[103]|object[104]	new[100]|new[103]|new[104]	_	_
18-22	1746-1751	brain	abstract[100]|abstract[103]|object[104]	new[100]|new[103]|new[104]	_	_
18-23	1752-1753	,	abstract[100]|abstract[103]	new[100]|new[103]	_	_
18-24	1754-1759	heart	abstract[100]|abstract[103]|place	new[100]|new[103]|new	_	_
18-25	1760-1761	,	abstract[100]|abstract[103]	new[100]|new[103]	_	_
18-26	1762-1768	kidney	abstract[100]|abstract[103]|place	new[100]|new[103]|new	_	_
18-27	1769-1770	,	abstract[100]|abstract[103]	new[100]|new[103]	_	_
18-28	1771-1774	and	abstract[100]|abstract[103]	new[100]|new[103]	_	_
18-29	1775-1780	liver	abstract[100]|abstract[103]|object	new[100]|new[103]|new	coref	23-27[138_0]
18-30	1781-1782	.	_	_	_	_

#Text=The walls of blood vessels are damaged , provoking hemorrhagic diathesis .
19-1	1783-1786	The	object[108]	new[108]	_	_
19-2	1787-1792	walls	object[108]	new[108]	_	_
19-3	1793-1795	of	object[108]	new[108]	_	_
19-4	1796-1801	blood	object[108]|object[109]	new[108]|new[109]	_	_
19-5	1802-1809	vessels	object[108]|object[109]	new[108]|new[109]	_	_
19-6	1810-1813	are	_	_	_	_
19-7	1814-1821	damaged	_	_	_	_
19-8	1822-1823	,	_	_	_	_
19-9	1824-1833	provoking	_	_	_	_
19-10	1834-1845	hemorrhagic	abstract|abstract[111]	new|new[111]	_	_
19-11	1846-1855	diathesis	abstract[111]	new[111]	_	_
19-12	1856-1857	.	_	_	_	_

#Text=T-2 also affects animals , with monogastric animals being more susceptible than ruminants .
20-1	1858-1861	T-2	abstract	giv	ana	21-1
20-2	1862-1866	also	_	_	_	_
20-3	1867-1874	affects	_	_	_	_
20-4	1875-1882	animals	animal	new	_	_
20-5	1883-1884	,	_	_	_	_
20-6	1885-1889	with	_	_	_	_
20-7	1890-1901	monogastric	animal[114]	new[114]	coref	23-21[0_114]
20-8	1902-1909	animals	animal[114]	new[114]	_	_
20-9	1910-1915	being	_	_	_	_
20-10	1916-1920	more	_	_	_	_
20-11	1921-1932	susceptible	_	_	_	_
20-12	1933-1937	than	_	_	_	_
20-13	1938-1947	ruminants	animal	new	coref	21-4[117_0]
20-14	1948-1949	.	_	_	_	_

#Text=This is because ruminants , such as cattle , possess a rumen where de-acetylation and de-epoxidation of the toxin take place , thus limiting its toxicity .
21-1	1950-1954	This	abstract	giv	ana	21-25
21-2	1955-1957	is	_	_	_	_
21-3	1958-1965	because	_	_	_	_
21-4	1966-1975	ruminants	animal[117]	giv[117]	_	_
21-5	1976-1977	,	animal[117]	giv[117]	_	_
21-6	1978-1982	such	animal[117]	giv[117]	_	_
21-7	1983-1985	as	animal[117]	giv[117]	_	_
21-8	1986-1992	cattle	animal[117]|animal	giv[117]|new	_	_
21-9	1993-1994	,	_	_	_	_
21-10	1995-2002	possess	_	_	_	_
21-11	2003-2004	a	substance[119]	new[119]	_	_
21-12	2005-2010	rumen	substance[119]	new[119]	_	_
21-13	2011-2016	where	_	_	_	_
21-14	2017-2031	de-acetylation	abstract	new	_	_
21-15	2032-2035	and	_	_	_	_
21-16	2036-2050	de-epoxidation	event[121]	new[121]	_	_
21-17	2051-2053	of	event[121]	new[121]	_	_
21-18	2054-2057	the	event[121]|substance[122]	new[121]|giv[122]	coref	22-1[125_122]
21-19	2058-2063	toxin	event[121]|substance[122]	new[121]|giv[122]	_	_
21-20	2064-2068	take	_	_	_	_
21-21	2069-2074	place	_	_	_	_
21-22	2075-2076	,	_	_	_	_
21-23	2077-2081	thus	_	_	_	_
21-24	2082-2090	limiting	_	_	_	_
21-25	2091-2094	its	abstract|abstract[124]	giv|giv[124]	coref|coref|coref|coref	36-25[0_124]|36-28|36-25[0_124]|36-28
21-26	2095-2103	toxicity	abstract[124]	giv[124]	_	_
21-27	2104-2105	.	_	_	_	_

#Text=The toxin also affects poultry , causing ulcerative and necrotic lesions as well as oral lesions , thereby leading to refusal of feed .
22-1	2106-2109	The	substance[125]	giv[125]	coref	23-5[133_125]
22-2	2110-2115	toxin	substance[125]	giv[125]	_	_
22-3	2116-2120	also	_	_	_	_
22-4	2121-2128	affects	_	_	_	_
22-5	2129-2136	poultry	animal	new	_	_
22-6	2137-2138	,	_	_	_	_
22-7	2139-2146	causing	_	_	_	_
22-8	2147-2157	ulcerative	abstract	new	_	_
22-9	2158-2161	and	_	_	_	_
22-10	2162-2170	necrotic	abstract[128]	new[128]	_	_
22-11	2171-2178	lesions	abstract[128]	new[128]	_	_
22-12	2179-2181	as	_	_	_	_
22-13	2182-2186	well	_	_	_	_
22-14	2187-2189	as	_	_	_	_
22-15	2190-2194	oral	object[129]	new[129]	_	_
22-16	2195-2202	lesions	object[129]	new[129]	_	_
22-17	2203-2204	,	_	_	_	_
22-18	2205-2212	thereby	_	_	_	_
22-19	2213-2220	leading	_	_	_	_
22-20	2221-2223	to	_	_	_	_
22-21	2224-2231	refusal	event[130]	new[130]	_	_
22-22	2232-2234	of	event[130]	new[130]	_	_
22-23	2235-2239	feed	event[130]|substance	new[130]|new	coref	32-8[212_0]
22-24	2240-2241	.	_	_	_	_

#Text=Studies have revealed that T-2 toxin is easily absorbed in the intestinal tract and is toxic to the organs of animals affecting the digestive system and liver of animals .
23-1	2242-2249	Studies	abstract	new	coref	42-19[279_0]
23-2	2250-2254	have	_	_	_	_
23-3	2255-2263	revealed	_	_	_	_
23-4	2264-2268	that	_	_	_	_
23-5	2269-2272	T-2	substance[133]	giv[133]	coref	36-28[243_133]
23-6	2273-2278	toxin	substance[133]	giv[133]	_	_
23-7	2279-2281	is	_	_	_	_
23-8	2282-2288	easily	_	_	_	_
23-9	2289-2297	absorbed	_	_	_	_
23-10	2298-2300	in	_	_	_	_
23-11	2301-2304	the	object[134]	giv[134]	_	_
23-12	2305-2315	intestinal	object[134]	giv[134]	_	_
23-13	2316-2321	tract	object[134]	giv[134]	_	_
23-14	2322-2325	and	_	_	_	_
23-15	2326-2328	is	_	_	_	_
23-16	2329-2334	toxic	_	_	_	_
23-17	2335-2337	to	_	_	_	_
23-18	2338-2341	the	abstract[135]	new[135]	_	_
23-19	2342-2348	organs	abstract[135]	new[135]	_	_
23-20	2349-2351	of	abstract[135]	new[135]	_	_
23-21	2352-2359	animals	abstract[135]|animal	new[135]|giv	coref	23-29
23-22	2360-2369	affecting	_	_	_	_
23-23	2370-2373	the	place[137]	giv[137]	_	_
23-24	2374-2383	digestive	place[137]	giv[137]	_	_
23-25	2384-2390	system	place[137]	giv[137]	_	_
23-26	2391-2394	and	_	_	_	_
23-27	2395-2400	liver	object[138]	giv[138]	_	_
23-28	2401-2403	of	object[138]	giv[138]	_	_
23-29	2404-2411	animals	object[138]|animal	giv[138]|giv	_	_
23-30	2412-2413	.	_	_	_	_

#Text=Decontamination processes involving physical , biological , and chemical methods are frequently required for the removal , destruction , and decontamination of mycotoxins .
24-1	2414-2429	Decontamination	abstract|abstract[141]	new|new[141]	_	_
24-2	2430-2439	processes	abstract[141]	new[141]	_	_
24-3	2440-2449	involving	abstract[141]	new[141]	_	_
24-4	2450-2458	physical	abstract[141]|abstract[142]	new[141]|new[142]	coref	27-7[165_142]
24-5	2459-2460	,	abstract[141]|abstract[142]	new[141]|new[142]	_	_
24-6	2461-2471	biological	abstract[141]|abstract[142]	new[141]|new[142]	_	_
24-7	2472-2473	,	abstract[141]|abstract[142]	new[141]|new[142]	_	_
24-8	2474-2477	and	abstract[141]|abstract[142]	new[141]|new[142]	_	_
24-9	2478-2486	chemical	abstract[141]|abstract[142]	new[141]|new[142]	_	_
24-10	2487-2494	methods	abstract[141]|abstract[142]	new[141]|new[142]	_	_
24-11	2495-2498	are	_	_	_	_
24-12	2499-2509	frequently	_	_	_	_
24-13	2510-2518	required	_	_	_	_
24-14	2519-2522	for	_	_	_	_
24-15	2523-2526	the	event[143]	new[143]	_	_
24-16	2527-2534	removal	event[143]	new[143]	_	_
24-17	2535-2536	,	_	_	_	_
24-18	2537-2548	destruction	event	new	_	_
24-19	2549-2550	,	_	_	_	_
24-20	2551-2554	and	_	_	_	_
24-21	2555-2570	decontamination	substance[145]	new[145]	coref	28-19[0_145]
24-22	2571-2573	of	substance[145]	new[145]	_	_
24-23	2574-2584	mycotoxins	substance[145]|substance	new[145]|giv	coref	25-20
24-24	2585-2586	.	_	_	_	_

#Text=Biological approaches include the activity of microorganisms ( algae , bacteria , filamentous fungi , and yeasts ) against mycotoxins using antibiosis or competition for nutrients and space .
25-1	2587-2597	Biological	abstract[147]	new[147]	coref	26-1[156_147]
25-2	2598-2608	approaches	abstract[147]	new[147]	_	_
25-3	2609-2616	include	_	_	_	_
25-4	2617-2620	the	abstract[148]	new[148]	_	_
25-5	2621-2629	activity	abstract[148]	new[148]	_	_
25-6	2630-2632	of	abstract[148]	new[148]	_	_
25-7	2633-2647	microorganisms	abstract[148]|animal	new[148]|new	_	_
25-8	2648-2649	(	_	_	_	_
25-9	2650-2655	algae	_	_	_	_
25-10	2656-2657	,	_	_	_	_
25-11	2658-2666	bacteria	_	_	_	_
25-12	2667-2668	,	_	_	_	_
25-13	2669-2680	filamentous	person	new	_	_
25-14	2681-2686	fungi	_	_	_	_
25-15	2687-2688	,	_	_	_	_
25-16	2689-2692	and	_	_	_	_
25-17	2693-2699	yeasts	_	_	_	_
25-18	2700-2701	)	_	_	_	_
25-19	2702-2709	against	_	_	_	_
25-20	2710-2720	mycotoxins	substance	giv	coref	26-6
25-21	2721-2726	using	_	_	_	_
25-22	2727-2737	antibiosis	abstract	new	_	_
25-23	2738-2740	or	_	_	_	_
25-24	2741-2752	competition	abstract	new	_	_
25-25	2753-2756	for	_	_	_	_
25-26	2757-2766	nutrients	substance	new	_	_
25-27	2767-2770	and	_	_	_	_
25-28	2771-2776	space	place	new	_	_
25-29	2777-2778	.	_	_	_	_

#Text=Chemical approaches help to degrade mycotoxins by various gases , aldehydes , oxidizing agents , acids , and bases .
26-1	2779-2787	Chemical	abstract[156]	giv[156]	_	_
26-2	2788-2798	approaches	abstract[156]	giv[156]	_	_
26-3	2799-2803	help	_	_	_	_
26-4	2804-2806	to	_	_	_	_
26-5	2807-2814	degrade	_	_	_	_
26-6	2815-2825	mycotoxins	substance	giv	coref	27-13[167_0]
26-7	2826-2828	by	_	_	_	_
26-8	2829-2836	various	substance[158]	new[158]	_	_
26-9	2837-2842	gases	substance[158]	new[158]	_	_
26-10	2843-2844	,	_	_	_	_
26-11	2845-2854	aldehydes	substance	new	_	_
26-12	2855-2856	,	_	_	_	_
26-13	2857-2866	oxidizing	person[160]	new[160]	coref	32-20[0_160]
26-14	2867-2873	agents	person[160]	new[160]	_	_
26-15	2874-2875	,	_	_	_	_
26-16	2876-2881	acids	substance	new	_	_
26-17	2882-2883	,	_	_	_	_
26-18	2884-2887	and	_	_	_	_
26-19	2888-2893	bases	substance	new	_	_
26-20	2894-2895	.	_	_	_	_

#Text=The EC supports the application of physical methods and sorting procedures for decontaminating mycotoxins .
27-1	2896-2899	The	organization[163]	new[163]	_	_
27-2	2900-2902	EC	organization[163]	new[163]	_	_
27-3	2903-2911	supports	_	_	_	_
27-4	2912-2915	the	abstract[164]	new[164]	_	_
27-5	2916-2927	application	abstract[164]	new[164]	_	_
27-6	2928-2930	of	abstract[164]	new[164]	_	_
27-7	2931-2939	physical	abstract[164]|abstract[165]	new[164]|giv[165]	coref	29-1[176_165]
27-8	2940-2947	methods	abstract[164]|abstract[165]	new[164]|giv[165]	_	_
27-9	2948-2951	and	_	_	_	_
27-10	2952-2959	sorting	_	_	_	_
27-11	2960-2970	procedures	abstract	new	_	_
27-12	2971-2974	for	_	_	_	_
27-13	2975-2990	decontaminating	person[167]	giv[167]	coref	28-10[0_167]
27-14	2991-3001	mycotoxins	person[167]	giv[167]	_	_
27-15	3002-3003	.	_	_	_	_

#Text=However , neither the mixing of batches to reduce mycotoxins to levels below the maximum tolerable limits nor decontamination using chemicals is permitted by the European Union .
28-1	3004-3011	However	_	_	_	_
28-2	3012-3013	,	_	_	_	_
28-3	3014-3021	neither	abstract[168]	new[168]	_	_
28-4	3022-3025	the	abstract[168]	new[168]	_	_
28-5	3026-3032	mixing	abstract[168]	new[168]	_	_
28-6	3033-3035	of	abstract[168]	new[168]	_	_
28-7	3036-3043	batches	abstract[168]|object	new[168]|new	_	_
28-8	3044-3046	to	_	_	_	_
28-9	3047-3053	reduce	_	_	_	_
28-10	3054-3064	mycotoxins	substance	giv	coref	33-16
28-11	3065-3067	to	_	_	_	_
28-12	3068-3074	levels	abstract	new	_	_
28-13	3075-3080	below	_	_	_	_
28-14	3081-3084	the	quantity[172]	new[172]	_	_
28-15	3085-3092	maximum	quantity[172]	new[172]	_	_
28-16	3093-3102	tolerable	quantity[172]	new[172]	_	_
28-17	3103-3109	limits	quantity[172]	new[172]	_	_
28-18	3110-3113	nor	_	_	_	_
28-19	3114-3129	decontamination	substance	giv	coref	31-24
28-20	3130-3135	using	_	_	_	_
28-21	3136-3145	chemicals	substance	new	_	_
28-22	3146-3148	is	_	_	_	_
28-23	3149-3158	permitted	_	_	_	_
28-24	3159-3161	by	_	_	_	_
28-25	3162-3165	the	organization[175]	new[175]	_	_
28-26	3166-3174	European	organization[175]	new[175]	_	_
28-27	3175-3180	Union	organization[175]	new[175]	_	_
28-28	3181-3182	.	_	_	_	_

#Text=Physical methods of detoxification include irradiation ( gamma or ultraviolet irradiation ) , solvent extraction , inactivation by heat , and the use of mineral adsorbents ( mainly clays ) .
29-1	3183-3191	Physical	abstract[176]	giv[176]	coref	31-18[205_176]
29-2	3192-3199	methods	abstract[176]	giv[176]	_	_
29-3	3200-3202	of	abstract[176]	giv[176]	_	_
29-4	3203-3217	detoxification	abstract[176]|abstract	giv[176]|new	_	_
29-5	3218-3225	include	_	_	_	_
29-6	3226-3237	irradiation	substance	new	appos	29-8[179_0]
29-7	3238-3239	(	_	_	_	_
29-8	3240-3245	gamma	substance[179]	giv[179]	coref	30-4[190_179]
29-9	3246-3248	or	substance[179]	giv[179]	_	_
29-10	3249-3260	ultraviolet	substance[179]	giv[179]	_	_
29-11	3261-3272	irradiation	substance[179]	giv[179]	_	_
29-12	3273-3274	)	_	_	_	_
29-13	3275-3276	,	_	_	_	_
29-14	3277-3284	solvent	substance|event[181]	new|new[181]	_	_
29-15	3285-3295	extraction	event[181]	new[181]	_	_
29-16	3296-3297	,	_	_	_	_
29-17	3298-3310	inactivation	event[182]	new[182]	coref	30-20[195_182]
29-18	3311-3313	by	event[182]	new[182]	_	_
29-19	3314-3318	heat	event[182]|substance	new[182]|new	coref	30-22
29-20	3319-3320	,	_	_	_	_
29-21	3321-3324	and	_	_	_	_
29-22	3325-3328	the	abstract[184]	new[184]	_	_
29-23	3329-3332	use	abstract[184]	new[184]	_	_
29-24	3333-3335	of	abstract[184]	new[184]	_	_
29-25	3336-3343	mineral	abstract[184]|substance|substance[186]	new[184]|new|new[186]	appos|coref|appos|coref	29-28[187_186]|31-4|29-28[187_186]|31-4
29-26	3344-3354	adsorbents	abstract[184]|substance[186]	new[184]|new[186]	_	_
29-27	3355-3356	(	_	_	_	_
29-28	3357-3363	mainly	substance[187]	giv[187]	coref	31-4[202_187]
29-29	3364-3369	clays	substance[187]	giv[187]	_	_
29-30	3370-3371	)	_	_	_	_
29-31	3372-3373	.	_	_	_	_

#Text=The disadvantages of food irradiation are the high costs involved and loss of vitamins ( avitaminosis ) , while inactivation by heat may lead to a loss in nutritional properties of the commodities .
30-1	3374-3377	The	abstract[188]	new[188]	coref	30-7[191_188]
30-2	3378-3391	disadvantages	abstract[188]	new[188]	_	_
30-3	3392-3394	of	abstract[188]	new[188]	_	_
30-4	3395-3399	food	abstract[188]|substance|substance[190]	new[188]|new|giv[190]	_	_
30-5	3400-3411	irradiation	abstract[188]|substance[190]	new[188]|giv[190]	_	_
30-6	3412-3415	are	_	_	_	_
30-7	3416-3419	the	abstract[191]	giv[191]	_	_
30-8	3420-3424	high	abstract[191]	giv[191]	_	_
30-9	3425-3430	costs	abstract[191]	giv[191]	_	_
30-10	3431-3439	involved	_	_	_	_
30-11	3440-3443	and	_	_	_	_
30-12	3444-3448	loss	abstract[192]	new[192]	coref	30-26[197_192]
30-13	3449-3451	of	abstract[192]	new[192]	_	_
30-14	3452-3460	vitamins	abstract[192]|substance	new[192]|new	_	_
30-15	3461-3462	(	_	_	_	_
30-16	3463-3475	avitaminosis	abstract	new	_	_
30-17	3476-3477	)	_	_	_	_
30-18	3478-3479	,	_	_	_	_
30-19	3480-3485	while	_	_	_	_
30-20	3486-3498	inactivation	event[195]	giv[195]	_	_
30-21	3499-3501	by	event[195]	giv[195]	_	_
30-22	3502-3506	heat	event[195]|abstract	giv[195]|giv	_	_
30-23	3507-3510	may	_	_	_	_
30-24	3511-3515	lead	_	_	_	_
30-25	3516-3518	to	_	_	_	_
30-26	3519-3520	a	abstract[197]	giv[197]	_	_
30-27	3521-3525	loss	abstract[197]	giv[197]	_	_
30-28	3526-3528	in	abstract[197]	giv[197]	_	_
30-29	3529-3540	nutritional	abstract[197]|abstract[198]	giv[197]|new[198]	coref	31-22[209_198]
30-30	3541-3551	properties	abstract[197]|abstract[198]	giv[197]|new[198]	_	_
30-31	3552-3554	of	abstract[197]|abstract[198]	giv[197]|new[198]	_	_
30-32	3555-3558	the	abstract[197]|abstract[198]|substance[199]	giv[197]|new[198]|new[199]	ana	31-22[0_199]
30-33	3559-3570	commodities	abstract[197]|abstract[198]|substance[199]	giv[197]|new[198]|new[199]	_	_
30-34	3571-3572	.	_	_	_	_

#Text=The use of mineral adsorbents , such as clay , is a cheaper and safer alternative to these methods , revealing their mycotoxin decontamination properties .
31-1	3573-3576	The	abstract[200]	new[200]	coref	31-12[204_200]
31-2	3577-3580	use	abstract[200]	new[200]	_	_
31-3	3581-3583	of	abstract[200]	new[200]	_	_
31-4	3584-3591	mineral	abstract[200]|substance|substance[202]	new[200]|giv|giv[202]	coref|coref	32-1[0_202]|32-1[0_202]
31-5	3592-3602	adsorbents	abstract[200]|substance[202]	new[200]|giv[202]	_	_
31-6	3603-3604	,	abstract[200]|substance[202]	new[200]|giv[202]	_	_
31-7	3605-3609	such	abstract[200]|substance[202]	new[200]|giv[202]	_	_
31-8	3610-3612	as	abstract[200]|substance[202]	new[200]|giv[202]	_	_
31-9	3613-3617	clay	abstract[200]|substance[202]|substance	new[200]|giv[202]|new	coref	34-1[226_0]
31-10	3618-3619	,	_	_	_	_
31-11	3620-3622	is	_	_	_	_
31-12	3623-3624	a	abstract[204]	giv[204]	coref	34-15[230_204]
31-13	3625-3632	cheaper	abstract[204]	giv[204]	_	_
31-14	3633-3636	and	abstract[204]	giv[204]	_	_
31-15	3637-3642	safer	abstract[204]	giv[204]	_	_
31-16	3643-3654	alternative	abstract[204]	giv[204]	_	_
31-17	3655-3657	to	abstract[204]	giv[204]	_	_
31-18	3658-3663	these	abstract[204]|abstract[205]	giv[204]|giv[205]	_	_
31-19	3664-3671	methods	abstract[204]|abstract[205]	giv[204]|giv[205]	_	_
31-20	3672-3673	,	_	_	_	_
31-21	3674-3683	revealing	_	_	_	_
31-22	3684-3689	their	substance|abstract[209]	giv|giv[209]	ana|ana	32-12[0_209]|32-12[0_209]
31-23	3690-3699	mycotoxin	substance|abstract[209]	new|giv[209]	coref	37-15
31-24	3700-3715	decontamination	substance|abstract[209]	giv|giv[209]	coref	37-16
31-25	3716-3726	properties	abstract[209]	giv[209]	_	_
31-26	3727-3728	.	_	_	_	_

#Text=Clays also serve as anti-caking agents in animal feed , and they are highly regarded as effective mycotoxin binding agents in animal feeds by enterosorption .
32-1	3729-3734	Clays	substance	giv	_	_
32-2	3735-3739	also	_	_	_	_
32-3	3740-3745	serve	_	_	_	_
32-4	3746-3748	as	_	_	_	_
32-5	3749-3760	anti-caking	_	_	_	_
32-6	3761-3767	agents	_	_	_	_
32-7	3768-3770	in	_	_	_	_
32-8	3771-3777	animal	animal|substance[212]	new|giv[212]	coref|coref|coref|coref	32-22|33-18[224_212]|32-22|33-18[224_212]
32-9	3778-3782	feed	substance[212]	giv[212]	_	_
32-10	3783-3784	,	_	_	_	_
32-11	3785-3788	and	_	_	_	_
32-12	3789-3793	they	abstract	giv	_	_
32-13	3794-3797	are	_	_	_	_
32-14	3798-3804	highly	_	_	_	_
32-15	3805-3813	regarded	_	_	_	_
32-16	3814-3816	as	_	_	_	_
32-17	3817-3826	effective	_	_	_	_
32-18	3827-3836	mycotoxin	_	_	_	_
32-19	3837-3844	binding	_	_	_	_
32-20	3845-3851	agents	person	giv	_	_
32-21	3852-3854	in	_	_	_	_
32-22	3855-3861	animal	animal|substance[216]	giv|new[216]	coref|coref	33-18|33-18
32-23	3862-3867	feeds	substance[216]	new[216]	_	_
32-24	3868-3870	by	_	_	_	_
32-25	3871-3885	enterosorption	abstract	new	_	_
32-26	3886-3887	.	_	_	_	_

#Text=Enzymes such as oxidoreductases and hydrolases have also been thoroughly explored in the mitigation of mycotoxins in animal feed .
33-1	3888-3895	Enzymes	substance[218]	new[218]	_	_
33-2	3896-3900	such	substance[218]	new[218]	_	_
33-3	3901-3903	as	substance[218]	new[218]	_	_
33-4	3904-3919	oxidoreductases	substance[218]|substance	new[218]|new	_	_
33-5	3920-3923	and	substance[218]	new[218]	_	_
33-6	3924-3934	hydrolases	substance[218]|substance	new[218]|new	_	_
33-7	3935-3939	have	_	_	_	_
33-8	3940-3944	also	_	_	_	_
33-9	3945-3949	been	_	_	_	_
33-10	3950-3960	thoroughly	_	_	_	_
33-11	3961-3969	explored	_	_	_	_
33-12	3970-3972	in	_	_	_	_
33-13	3973-3976	the	abstract[221]	new[221]	_	_
33-14	3977-3987	mitigation	abstract[221]	new[221]	_	_
33-15	3988-3990	of	abstract[221]	new[221]	_	_
33-16	3991-4001	mycotoxins	abstract[221]|person	new[221]|giv	_	_
33-17	4002-4004	in	abstract[221]	new[221]	_	_
33-18	4005-4011	animal	abstract[221]|animal|substance[224]	new[221]|giv|giv[224]	_	_
33-19	4012-4016	feed	abstract[221]|substance[224]	new[221]|giv[224]	_	_
33-20	4017-4018	.	_	_	_	_

#Text=Montmorillonite clay has pharmaceutical applications where it serves as an excipient in drugs for oral or topical use .
34-1	4019-4034	Montmorillonite	abstract|substance[226]	new|giv[226]	ana|coref|ana|coref	34-7[0_226]|35-4|34-7[0_226]|35-4
34-2	4035-4039	clay	substance[226]	giv[226]	_	_
34-3	4040-4043	has	_	_	_	_
34-4	4044-4058	pharmaceutical	abstract[227]	new[227]	_	_
34-5	4059-4071	applications	abstract[227]	new[227]	_	_
34-6	4072-4077	where	_	_	_	_
34-7	4078-4080	it	substance	giv	coref	35-4[233_0]
34-8	4081-4087	serves	_	_	_	_
34-9	4088-4090	as	_	_	_	_
34-10	4091-4093	an	_	_	_	_
34-11	4094-4103	excipient	_	_	_	_
34-12	4104-4106	in	_	_	_	_
34-13	4107-4112	drugs	substance[229]	new[229]	_	_
34-14	4113-4116	for	substance[229]	new[229]	_	_
34-15	4117-4121	oral	substance[229]|abstract[230]	new[229]|giv[230]	_	_
34-16	4122-4124	or	substance[229]|abstract[230]	new[229]|giv[230]	_	_
34-17	4125-4132	topical	substance[229]|abstract[230]	new[229]|giv[230]	_	_
34-18	4133-4136	use	substance[229]|abstract[230]	new[229]|giv[230]	_	_
34-19	4137-4138	.	_	_	_	_

#Text=The cytotoxicity of montmorillonite clay is low both in vitro and in vivo .
35-1	4139-4142	The	abstract[231]	new[231]	_	_
35-2	4143-4155	cytotoxicity	abstract[231]	new[231]	_	_
35-3	4156-4158	of	abstract[231]	new[231]	_	_
35-4	4159-4174	montmorillonite	abstract[231]|abstract|substance[233]	new[231]|giv|giv[233]	coref|coref|coref|coref	37-3[0_233]|38-1|37-3[0_233]|38-1
35-5	4175-4179	clay	abstract[231]|substance[233]	new[231]|giv[233]	_	_
35-6	4180-4182	is	_	_	_	_
35-7	4183-4186	low	_	_	_	_
35-8	4187-4191	both	_	_	_	_
35-9	4192-4194	in	_	_	_	_
35-10	4195-4200	vitro	_	_	_	_
35-11	4201-4204	and	_	_	_	_
35-12	4205-4207	in	_	_	_	_
35-13	4208-4212	vivo	_	_	_	_
35-14	4213-4214	.	_	_	_	_

#Text=A study by Wei et al. showed that modified hydrated sodium calcium aluminosilicate ( HSCAS ) adsorbent could be used in vivo to reduce toxicity induced by T-2 toxin .
36-1	4215-4216	A	abstract[234]	new[234]	_	_
36-2	4217-4222	study	abstract[234]	new[234]	_	_
36-3	4223-4225	by	abstract[234]	new[234]	_	_
36-4	4226-4229	Wei	abstract[234]|person	new[234]|new	_	_
36-5	4230-4232	et	abstract[234]	new[234]	_	_
36-6	4233-4236	al.	abstract[234]	new[234]	_	_
36-7	4237-4243	showed	_	_	_	_
36-8	4244-4248	that	_	_	_	_
36-9	4249-4257	modified	_	_	_	_
36-10	4258-4266	hydrated	substance[238]	new[238]	appos	36-15[0_238]
36-11	4267-4273	sodium	substance|substance[238]	new|new[238]	_	_
36-12	4274-4281	calcium	substance|substance[238]	new|new[238]	_	_
36-13	4282-4297	aluminosilicate	substance[238]	new[238]	_	_
36-14	4298-4299	(	_	_	_	_
36-15	4300-4305	HSCAS	substance	giv	_	_
36-16	4306-4307	)	_	_	_	_
36-17	4308-4317	adsorbent	substance	new	_	_
36-18	4318-4323	could	_	_	_	_
36-19	4324-4326	be	_	_	_	_
36-20	4327-4331	used	_	_	_	_
36-21	4332-4334	in	_	_	_	_
36-22	4335-4339	vivo	_	_	_	_
36-23	4340-4342	to	_	_	_	_
36-24	4343-4349	reduce	_	_	_	_
36-25	4350-4358	toxicity	abstract	giv	_	_
36-26	4359-4366	induced	_	_	_	_
36-27	4367-4369	by	_	_	_	_
36-28	4370-4373	T-2	abstract|substance[243]	giv|giv[243]	_	_
36-29	4374-4379	toxin	substance[243]	giv[243]	_	_
36-30	4380-4381	.	_	_	_	_

#Text=Therefore , clay can be safely expended in the storage of cereal crops for mycotoxin decontamination purposes .
37-1	4382-4391	Therefore	_	_	_	_
37-2	4392-4393	,	_	_	_	_
37-3	4394-4398	clay	substance	giv	_	_
37-4	4399-4402	can	_	_	_	_
37-5	4403-4405	be	_	_	_	_
37-6	4406-4412	safely	_	_	_	_
37-7	4413-4421	expended	_	_	_	_
37-8	4422-4424	in	_	_	_	_
37-9	4425-4428	the	abstract[245]	new[245]	_	_
37-10	4429-4436	storage	abstract[245]	new[245]	_	_
37-11	4437-4439	of	abstract[245]	new[245]	_	_
37-12	4440-4446	cereal	abstract[245]|substance|plant[247]	new[245]|new|new[247]	_	_
37-13	4447-4452	crops	abstract[245]|plant[247]	new[245]|new[247]	_	_
37-14	4453-4456	for	abstract[245]	new[245]	_	_
37-15	4457-4466	mycotoxin	abstract[245]|substance|abstract[250]	new[245]|giv|new[250]	_	_
37-16	4467-4482	decontamination	abstract[245]|substance|abstract[250]	new[245]|giv|new[250]	_	_
37-17	4483-4491	purposes	abstract[245]|abstract[250]	new[245]|new[250]	_	_
37-18	4492-4493	.	_	_	_	_

#Text=Montmorillonite , when compared with other nanoclays , has an advantage because it is abundant and environmentally friendly .
38-1	4494-4509	Montmorillonite	place	giv	coref	39-4
38-2	4510-4511	,	_	_	_	_
38-3	4512-4516	when	_	_	_	_
38-4	4517-4525	compared	_	_	_	_
38-5	4526-4530	with	_	_	_	_
38-6	4531-4536	other	object[252]	new[252]	_	_
38-7	4537-4546	nanoclays	object[252]	new[252]	_	_
38-8	4547-4548	,	_	_	_	_
38-9	4549-4552	has	_	_	_	_
38-10	4553-4555	an	abstract[253]	new[253]	ana	38-13[0_253]
38-11	4556-4565	advantage	abstract[253]	new[253]	_	_
38-12	4566-4573	because	_	_	_	_
38-13	4574-4576	it	abstract	giv	_	_
38-14	4577-4579	is	_	_	_	_
38-15	4580-4588	abundant	_	_	_	_
38-16	4589-4592	and	_	_	_	_
38-17	4593-4608	environmentally	_	_	_	_
38-18	4609-4617	friendly	_	_	_	_
38-19	4618-4619	.	_	_	_	_

#Text=Each layer of montmorillonite has a lateral dimension of 200 – 600 nm .
39-1	4620-4624	Each	object[255]	new[255]	_	_
39-2	4625-4630	layer	object[255]	new[255]	_	_
39-3	4631-4633	of	object[255]	new[255]	_	_
39-4	4634-4649	montmorillonite	object[255]|object	new[255]|giv	ana	40-1
39-5	4650-4653	has	_	_	_	_
39-6	4654-4655	a	abstract[257]	new[257]	_	_
39-7	4656-4663	lateral	abstract[257]	new[257]	_	_
39-8	4664-4673	dimension	abstract[257]	new[257]	_	_
39-9	4674-4676	of	abstract[257]	new[257]	_	_
39-10	4677-4680	200	abstract[257]|quantity[258]	new[257]|new[258]	_	_
39-11	4681-4682	–	abstract[257]|quantity[258]	new[257]|new[258]	_	_
39-12	4683-4686	600	abstract[257]|quantity[258]|quantity[259]	new[257]|new[258]|new[259]	_	_
39-13	4687-4689	nm	abstract[257]|quantity[258]|quantity[259]	new[257]|new[258]|new[259]	_	_
39-14	4690-4691	.	_	_	_	_

#Text=It is made up of an octahedral sheet sandwiched between two tetrahedral sheets .
40-1	4692-4694	It	place	giv	coref	42-14
40-2	4695-4697	is	_	_	_	_
40-3	4698-4702	made	_	_	_	_
40-4	4703-4705	up	_	_	_	_
40-5	4706-4708	of	_	_	_	_
40-6	4709-4711	an	object[261]	new[261]	_	_
40-7	4712-4722	octahedral	object[261]	new[261]	_	_
40-8	4723-4728	sheet	object[261]	new[261]	_	_
40-9	4729-4739	sandwiched	_	_	_	_
40-10	4740-4747	between	_	_	_	_
40-11	4748-4751	two	object[262]	new[262]	coref	41-4[264_262]
40-12	4752-4763	tetrahedral	object[262]	new[262]	_	_
40-13	4764-4770	sheets	object[262]	new[262]	_	_
40-14	4771-4772	.	_	_	_	_

#Text=The arrangement of the sheets is such that the silicon oxide tetrahedron ( SiO4 ) shares three out of four of its oxygen atoms with the central octahedral sheets .
41-1	4773-4776	The	abstract[263]	new[263]	_	_
41-2	4777-4788	arrangement	abstract[263]	new[263]	_	_
41-3	4789-4791	of	abstract[263]	new[263]	_	_
41-4	4792-4795	the	abstract[263]|object[264]	new[263]|giv[264]	coref	41-22[272_264]
41-5	4796-4802	sheets	abstract[263]|object[264]	new[263]|giv[264]	_	_
41-6	4803-4805	is	_	_	_	_
41-7	4806-4810	such	_	_	_	_
41-8	4811-4815	that	_	_	_	_
41-9	4816-4819	the	abstract[266]	new[266]	ana	41-22[0_266]
41-10	4820-4827	silicon	object|abstract[266]	new|new[266]	_	_
41-11	4828-4833	oxide	abstract[266]	new[266]	_	_
41-12	4834-4845	tetrahedron	_	_	_	_
41-13	4846-4847	(	_	_	_	_
41-14	4848-4852	SiO4	object	new	_	_
41-15	4853-4854	)	_	_	_	_
41-16	4855-4861	shares	_	_	_	_
41-17	4862-4867	three	quantity	new	_	_
41-18	4868-4871	out	_	_	_	_
41-19	4872-4874	of	_	_	_	_
41-20	4875-4879	four	quantity[269]	new[269]	_	_
41-21	4880-4882	of	quantity[269]	new[269]	_	_
41-22	4883-4886	its	quantity[269]|abstract|object[272]	new[269]|giv|giv[272]	_	_
41-23	4887-4893	oxygen	quantity[269]|substance|object[272]	new[269]|new|giv[272]	_	_
41-24	4894-4899	atoms	quantity[269]|object[272]	new[269]|giv[272]	_	_
41-25	4900-4904	with	object[272]	giv[272]	_	_
41-26	4905-4908	the	object[272]	giv[272]	_	_
41-27	4909-4916	central	object[272]	giv[272]	_	_
41-28	4917-4927	octahedral	object[272]	giv[272]	_	_
41-29	4928-4934	sheets	object[272]	giv[272]	_	_
41-30	4935-4936	.	_	_	_	_

#Text=Among various clay minerals such as kaolinite , illite , and chlorite , montmorillonite is more ideal for adsorption studies since it has a high cation exchange capacity , swelling capacity , and high surface area .
42-1	4937-4942	Among	_	_	_	_
42-2	4943-4950	various	substance[273]	new[273]	_	_
42-3	4951-4955	clay	substance[273]	new[273]	_	_
42-4	4956-4964	minerals	substance[273]	new[273]	_	_
42-5	4965-4969	such	substance[273]	new[273]	_	_
42-6	4970-4972	as	substance[273]	new[273]	_	_
42-7	4973-4982	kaolinite	substance[273]|substance	new[273]|new	_	_
42-8	4983-4984	,	substance[273]	new[273]	_	_
42-9	4985-4991	illite	substance[273]|substance	new[273]|new	_	_
42-10	4992-4993	,	substance[273]	new[273]	_	_
42-11	4994-4997	and	substance[273]	new[273]	_	_
42-12	4998-5006	chlorite	substance[273]|substance	new[273]|new	_	_
42-13	5007-5008	,	substance[273]	new[273]	_	_
42-14	5009-5024	montmorillonite	substance[273]|substance	new[273]|giv	ana	42-22
42-15	5025-5027	is	_	_	_	_
42-16	5028-5032	more	_	_	_	_
42-17	5033-5038	ideal	_	_	_	_
42-18	5039-5042	for	_	_	_	_
42-19	5043-5053	adsorption	abstract|abstract[279]	new|giv[279]	_	_
42-20	5054-5061	studies	abstract[279]	giv[279]	_	_
42-21	5062-5067	since	_	_	_	_
42-22	5068-5070	it	place	giv	_	_
42-23	5071-5074	has	_	_	_	_
42-24	5075-5076	a	abstract[283]	new[283]	_	_
42-25	5077-5081	high	abstract[283]	new[283]	_	_
42-26	5082-5088	cation	abstract|abstract[283]	new|new[283]	_	_
42-27	5089-5097	exchange	event|abstract[283]	new|new[283]	_	_
42-28	5098-5106	capacity	abstract[283]	new[283]	_	_
42-29	5107-5108	,	_	_	_	_
42-30	5109-5117	swelling	abstract[284]	new[284]	_	_
42-31	5118-5126	capacity	abstract[284]	new[284]	_	_
42-32	5127-5128	,	_	_	_	_
42-33	5129-5132	and	_	_	_	_
42-34	5133-5137	high	quantity[286]	new[286]	_	_
42-35	5138-5145	surface	place|quantity[286]	new|new[286]	_	_
42-36	5146-5150	area	quantity[286]	new[286]	_	_
42-37	5151-5152	.	_	_	_	_
